FY2025 · ended Dec 31, 2025 · Revenue $5.69M, +208.3% YoY · Filed Mar 30, 2026
Bioscience Health Innovations Inc. (BHIC) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.7 million and net income of $642,090.
Revenue (TTM)
$4.49M
+7.8% vs year-ago TTM
Net income (TTM)
$-658,072
-169.2% vs year-ago TTM
Operating cash flow (TTM)
$-1.54M
-349.5% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.06
Dividend per share
None
Shares outstanding
11.37M
-74.1% vs prior year
Net cash
—
Operating margin
-13.7%
FY 2026
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- BHIC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bluffdale, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1784440
- Former names
- Nowtransit Inc (until Mar 13, 2025)
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Aug 31, 2022 |
FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.7M | $1.8M | $597,595 | $0 | $0 |
| Operating income | $719,051 | $87,000 | -$251,500 | -$91,921 | -$25,610 |
| Net income | $642,090 | $87,000 | -$251,500 | -$83,208 | -$25,610 |
| Diluted EPS | $0.06 | $0.01 | — | — | — |
| Operating cash flow | $172,178 | $23,188 | -$307,842 | -$85,782 | -$29,439 |
| Total assets | $1.7M | $873,788 | $93,388 | $16,253 | $6,314 |
| Total liabilities | $229,851 | $38,548 | $100,148 | $1,860 | $19,106 |
| Stockholders' equity | $1.5M | $835,240 | -$6,760 | $14,393 | -$12,792 |
| Cash and investments | $661,925 | $662,517 | $19,238 | — | $2,035 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2026 | Apr 2, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Oct 27, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 16, 2025 | Sep 10, 2025 |
All 53 Bioscience Health Innovations Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.